Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ConverGene
AddedFeb 18, 2024
UpdatedJun 18, 2026
ConverGene

ConverGene

ConverGene, founded in 2011, specializes in small molecule drug discovery for cancer treatment, leveraging rational drug design.

HQ
Cambridge, MA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

ConverGene, founded in 2011, is a small molecule drug discovery company focused on developing therapeutics with novel mechanisms of action for cancer patients with limited or no treatment options. The company leverages rational drug design to target BET proteins, which are believed to be crucial for the epigenetic control of MYC. ConverGene aims to create first-in-class dual inhibitors targeting both BET bromodomains and Dopamine Receptor 2, addressing rare diseases and unmet medical needs.

The founding team comprises six leaders in genomics and personalized medicine, bringing extensive medicinal chemistry expertise. ConverGene has attracted notable investors and collaborators in the biotech industry, contributing to its innovative research and development efforts. The company's key achievements include advancing its drug candidates through preclinical stages and establishing strategic partnerships. ConverGene's impact lies in its potential to offer groundbreaking treatments for patients who currently have few therapeutic options.

ConverGene - Similar Companies

BridGene Biosciences logo

BridGene Biosciences

Convergent Therapeutics logo

Convergent Therapeutics

convergentrx.com

Cvergenx logo

Cvergenx

cvergenx.com

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Confluence Discovery Technologies logo

Confluence Discovery Technologies

ReveraGen BioPharma logo

ReveraGen BioPharma

reveragen.com

1910 logo

1910

1910genetics.com

Generian Pharmaceuticals logo

Generian Pharmaceuticals

generian.com

Variant Bio logo

Variant Bio

variantbio.com

GeneCentrix logo

GeneCentrix

genecentrix.com

Cargene logo

Cargene

cargene.com

TigerGene logo

TigerGene

Curie.Bio logo

Curie.Bio

curie.bio

Harmonic Discovery logo

Harmonic Discovery

Reactive Biosciences logo

Reactive Biosciences

reactivebio.com

ConverGene - Quick Facts

Who are ConverGene's competitors?

Companies similar to ConverGene include BridGene Biosciences, Convergent Therapeutics, Cvergenx and Cogent Biosciences.

When was ConverGene founded?

ConverGene was founded in 2011.

Where is ConverGene's headquarters located?

ConverGene's headquarters is located in Cambridge, MA, US.

When was ConverGene's last funding round?

ConverGene's most recent funding round was for $850k (USD) in April 2014.

How much has ConverGene raised to-date?

As of Apr 8, 2014, ConverGene has raised a total of $850k (USD).

How many employees does ConverGene have?

ConverGene has 6 employees as of Feb 5, 2024.

ConverGene - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research